Longer COVID vaccine dose interval tied to higher antibody levels - CIDRAP

Extending the time between COVID-19 vaccine doses to over 10 weeks was tied to 11 times higher antibody levels.

An interval of over 10 weeks between COVID-19 vaccine doses was associated with SARS-CoV-2 antibody levels up to 11 times higher than with an interval of 2 to 4 weeks in never-infected participants, … [+3439 chars]

full article...